[Drug UDCA (Ursosan) in therapeutic management of patients Barrett's esophagus].

Abstract

OBJECTIVE:

to evaluate the five-year prospective study the possibility of using the drug UDCA (Ursosan) for the therapeutic management of patients with BE older.

MATERIALS AND METHODS:

A prospective open randomized, parallel-group 62 patients of BE with a length of metaplasia less than 3 cm in average age 72.8 +/- 2.8 years. Method of "sealed envelopes" were divided into two equal groups. Patients first--received omeprazole at a daily dose of 40 mg, the second--to combine the same dose of omeprazole drug-Ursosan a daily dose of 10 mg/kg. At baseline and after 4.8+1.2 years assessed the frequency of esophageal, extraesophageal and dyspeptic complaints, endoscopic and morphological pattern of esophageal-gastric junction and lower third of the esophagus. Confirm or exclude the diagnosis of BE during follow-up study was performed after a two-fold endoscopy upper GIT using subdivision techniques for sampling biopsy material and subsequent analysis of biopsy samples pathomorphology of various medical institutions.

RESULTS:

The combination therapy with omeprazole and drug UDCA contributed to the positive dynamics is the lack of intestinal metaplasia in 32.3% of patients with Barrett's esophagus, whereas monotherapy with omeprazole in a daily dose of 40 mg possible to achieve a similar result in 6.5% of patients (p = 0,01). The frequency of diagnosis of erosive esophagitis decreased after 5 years of therapy with 80.6% to 51.6% (p = 0.016) in the omeprazole group and 86.7% to 16.7% (p < 0.001) in the group receiving omeprazole and the preparation of UDCA.

CONCLUSION:

This study suggests the possibility of combined therapy with omeprazole and the preparation of UDCA (Ursosan) as a promising means for hemopreventciya Barrett's esophagus in the elderly.

• Authors: E V Onuchina, V V Tsukanov, M F Osipenko
• Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (Eksp Klin Gastroenterol) Issue 12 Pg. 96-101 ( 2010) ISSN: 1682-8658 [Print] Russia (Federation)
• PMID: 21560631 (Publication Type: Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Ulcer Agents
• Cholagogues and Choleretics
• Ursodeoxycholic Acid
• Omeprazole

Topics

• Age Factors
• Aged
• Anti-Ulcer Agents (administration & dosage)
• Barrett Esophagus (diagnosis, drug therapy, physiopathology)
• Cholagogues and Choleretics (administration & dosage)
• Female
• Follow-Up Studies
• Humans
• Male
• Omeprazole (administration & dosage)
• Prospective Studies
• Ursodeoxycholic Acid (administration & dosage, analogs & derivatives)